Yoram Barak

Summary

Affiliation: Kosan Biosciences
Country: USA

Publications

  1. pmc Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing
    Yoram Barak
    Department of Microbiology and Immunology, Sherman Fairchild Science Building, Stanford University School of Medicine, 299 Campus Drive, Stanford, CA 94305, USA
    BMC Cancer 10:146. 2010
  2. pmc CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
    Steve H Thorne
    Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer Ther 8:333-41. 2009
  3. doi request reprint Enzyme improvement in the absence of structural knowledge: a novel statistical approach
    Yoram Barak
    Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
    ISME J 2:171-9. 2008
  4. ncbi request reprint New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution
    Yoram Barak
    Department of Microbiology and Immunology, Stanford University School of Medicine, Sherman Fairchild Science Building, 299 Campus Drive, Stanford, CA 94305, USA
    Mol Cancer Ther 5:97-103. 2006
  5. pmc Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria
    Michael R Benoit
    Department of Microbiology and Immunology, Stanford University, Stanford, California 94305 5124, USA
    Clin Cancer Res 15:5170-7. 2009

Collaborators

Detail Information

Publications5

  1. pmc Role of nitric oxide in Salmonella typhimurium-mediated cancer cell killing
    Yoram Barak
    Department of Microbiology and Immunology, Sherman Fairchild Science Building, Stanford University School of Medicine, 299 Campus Drive, Stanford, CA 94305, USA
    BMC Cancer 10:146. 2010
    ..Whether NO generation by the bacteria has a role in SL7838 lethality to cancer cells is explored. This bacterium has the mechanism for generating NO, but also for decomposing it...
  2. pmc CNOB/ChrR6, a new prodrug enzyme cancer chemotherapy
    Steve H Thorne
    Department of Pediatrics, Stanford University School of Medicine, Stanford, CA 94305, USA
    Mol Cancer Ther 8:333-41. 2009
    ..This feature may simplify exploration of barriers to the penetration of MCHB in tumors and their amelioration...
  3. doi request reprint Enzyme improvement in the absence of structural knowledge: a novel statistical approach
    Yoram Barak
    Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA 94305, USA
    ISME J 2:171-9. 2008
    ..Thus, the statistical model underlying the experiment was validated, and its predictions were shown to reduce laboratory labor and resources...
  4. ncbi request reprint New enzyme for reductive cancer chemotherapy, YieF, and its improvement by directed evolution
    Yoram Barak
    Department of Microbiology and Immunology, Stanford University School of Medicine, Sherman Fairchild Science Building, 299 Campus Drive, Stanford, CA 94305, USA
    Mol Cancer Ther 5:97-103. 2006
    ..Thus, Y6 is a promising enzyme for use in cancer chemotherapy, and Salmonella strain SL 7838, which specifically targets tumors, may be used to deliver the prodrug-activating enzymes to tumors...
  5. pmc Visualizing implanted tumors in mice with magnetic resonance imaging using magnetotactic bacteria
    Michael R Benoit
    Department of Microbiology and Immunology, Stanford University, Stanford, California 94305 5124, USA
    Clin Cancer Res 15:5170-7. 2009
    ..To determine if magnetotactic bacteria can target tumors in mice and provide positive contrast for visualization using magnetic resonance imaging...